Literature DB >> 9973937

A combined approach of conventional and molecular cytogenetics for detailed karyotypic analysis of the small cell lung carcinoma cell line U2020.

A C Heppell-Parton1, E Nacheva, N P Carter, P H Rabbitts.   

Abstract

Until recently the ability to analyze complex karyotypic rearrangements was totally dependent upon light microscopy of G-banded chromosomes. Developments in the area of molecular cytogenetics have revolutionized such analysis, making it possible to determine the nature of complex rearrangements. An extensive analysis has been made of the small cell lung carcinoma (SCLC) cell line U2020, using a combined approach of conventional and molecular cytogenetics, enabling a highly detailed karyotype to be constructed revealing rearrangements previously undetected by G-banding alone. This approach offers the opportunity to reassess other tumor karyotypes, particularly those of high complexity found in solid tumors, for tumor-specific consistent rearrangements indecipherable by conventional karyotyping.

Entities:  

Mesh:

Year:  1999        PMID: 9973937     DOI: 10.1016/s0165-4608(98)00130-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions.

Authors:  Eva Darai-Ramqvist; Agneta Sandlund; Stefan Müller; George Klein; Stefan Imreh; Maria Kost-Alimova
Journal:  Genome Res       Date:  2008-01-29       Impact factor: 9.043

2.  Array-CGH and multipoint FISH to decode complex chromosomal rearrangements.

Authors:  Eva Darai-Ramqvist; Teresita Diaz de Ståhl; Agneta Sandlund; Kiran Mantripragada; George Klein; Jan Dumanski; Stefan Imreh; Maria Kost-Alimova
Journal:  BMC Genomics       Date:  2006-12-29       Impact factor: 3.969

3.  Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.

Authors:  Vitaly I Loginov; Alexey A Dmitriev; Vera N Senchenko; Irina V Pronina; Dmitry S Khodyrev; Anna V Kudryavtseva; George S Krasnov; Ganna V Gerashchenko; Larisa I Chashchina; Tatiana P Kazubskaya; Tatiana T Kondratieva; Michael I Lerman; Debora Angeloni; Eleonora A Braga; Vladimir I Kashuba
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

4.  HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.

Authors:  Fuli Wang; Elvira V Grigorieva; Jingfeng Li; Vera N Senchenko; Tatiana V Pavlova; Ekaterina A Anedchenko; Anna V Kudryavtseva; Alexander Tsimanis; Debora Angeloni; Michael I Lerman; Vladimir I Kashuba; George Klein; Eugene R Zabarovsky
Journal:  PLoS One       Date:  2008-08-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.